EBioMedicine (Nov 2024)

Loss of heterozygosity exploited for collateral lethality-based cancer therapy

  • Hai Fang

DOI
https://doi.org/10.1016/j.ebiom.2024.105388
Journal volume & issue
Vol. 109
p. 105388

Abstract

Read online

No abstracts available.